This online article, in Croatian, summarizes a research review conducted to determine whether aripiprazole, an antipsychotic medication, is an effective treatment for severe behavior problems in people on the autism spectrum. The article concludes that evidence suggests aripiprazole can improve behavior issues in the short term, but side effects such as weight gain and involuntary tremors are possible.

The authors suggest that individuals taking aripiprazole should be periodically re-evaluated to monitor symptoms and side effects. The English version notes that one study showed similar long-term relapse rates in the placebo and treatment groups.

This resource is available in English, Croatian, French, German, Spanish, and Tamil.

Cochrane is a �global independent network of researchers, professionals, patients, carers, and people interested in health.� [Website] The network reviews evidence about health treatments.